Global Trust Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Global Trust Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50	Closed	-$5.01K	–	545
2025 Q3	$5.01K	Hold	50	–	–	﹤0.01%	420
2025 Q2	$4.15K	Hold	50	–	–	﹤0.01%	418
2025 Q1	$4.05K	Hold	50	–	–	﹤0.01%	405
2024 Q4	$4.5K	Hold	50	–	–	﹤0.01%	448
2024 Q3	$4.94K	Sell	50 -100	-67%	-$9.82K	﹤0.01%	415
2024 Q2	$13.9K	Hold	150	–	–	0.01%	343
2024 Q1	$14.2K	Hold	150	–	–	0.01%	338
2023 Q4	$13.4K	Buy	150 +100	+200%	+$7.43K	0.01%	325
2023 Q3	$3.65K	Hold	50	–	–	﹤0.01%	374
2023 Q2	$4.16K	Hold	50	–	–	﹤0.01%	373
2023 Q1	$3.81K	Hold	50	–	–	﹤0.01%	358
2022 Q4	$4.15K	Hold	50	–	–	﹤0.01%	344
2022 Q3	$4K	Hold	50	–	–	﹤0.01%	375
2022 Q2	$4K	Hold	50	–	–	﹤0.01%	367
2022 Q1	$4K	Hold	50	–	–	﹤0.01%	407
2021 Q4	$6K	Hold	50	–	–	﹤0.01%	362
2021 Q3	$6K	Hold	50	–	–	﹤0.01%	341
2021 Q2	$7K	Hold	50	–	–	﹤0.01%	344
2021 Q1	$7K	Hold	50	–	–	﹤0.01%	310
2020 Q4	$7K	Sell	50 -50	-50%	-$6.4K	﹤0.01%	317
2020 Q3	$11K	Hold	100	–	–	0.01%	262
2020 Q2	$11K	Buy	100 +50	+100%	+$4.92K	0.01%	239
2020 Q1	$4K	Hold	50	–	–	﹤0.01%	292
2019 Q4	$5K	Hold	50	–	–	﹤0.01%	318
2019 Q3	$4K	Hold	50	–	–	﹤0.01%	298
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	339
2019 Q1	$5K	Hold	50	–	–	﹤0.01%	301
2018 Q4	$4K	Hold	50	–	–	﹤0.01%	323
2018 Q3	$5K	Hold	50	–	–	﹤0.01%	345
2018 Q2	$5K	Hold	50	–	–	﹤0.01%	339
2018 Q1	$4K	Hold	50	–	–	﹤0.01%	334
2017 Q4	$4K	Buy	+50	New	+$4.19K	﹤0.01%	354

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Global Trust Asset Management's XBI Position: Q4 2025 in Review

Global Trust Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 50 shares — an estimated $5.01K sold.

Global Trust Asset Management first reported a position in XBI in Q4 2017 and held it in 32 quarters. The position peaked at $14.2K in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Global Trust Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Global Trust Asset Management sold 50 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $5.01K.
Global Trust Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 32 quarters.
Global Trust Asset Management's State Street SPDR S&P Biotech ETF position peaked at $14.2K in Q1 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Global Trust Asset Management's 13F filing for Q4 2025, filed 20 Jan 2026.